Literature DB >> 16898576

Intensive insulin therapy: is it effective in the medical intensive care unit?

Mary Ann Banerji, Mustafa Tiewala.   

Abstract

Entities:  

Year:  2006        PMID： 16898576     DOI： 10.1007/s11892-006-0039-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN： 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  7 in total

1.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  American College of Endocrinology position statement on inpatient diabetes and metabolic control.

Authors:  Alan J Garber; Etie S Moghissi; Edwin D Bransome; Nataniel G Clark; Stephen Clement; Rhoda H Cobin; Anthony P Furnary; Irl B Hirsch; Philip Levy; Robert Roberts; Greet Van den Berghe; Virginia Zamudio
Journal:  Endocr Pract       Date:  2004 Mar-Apr       Impact factor: 3.443

3.  Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

Authors:  Jean-Pierre Després; Alain Golay; Lars Sjöström
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

4.  Randomized trial of lifestyle modification and pharmacotherapy for obesity.

Authors:  Thomas A Wadden; Robert I Berkowitz; Leslie G Womble; David B Sarwer; Suzanne Phelan; Robert K Cato; Louise A Hesson; Suzette Y Osei; Rosalind Kaplan; Albert J Stunkard
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

6.  Long-term weight loss with sibutramine: a randomized controlled trial.

Authors:  A Wirth; J Krause
Journal:  JAMA       Date:  2001-09-19       Impact factor: 56.272

7.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Authors:  M H Davidson; J Hauptman; M DiGirolamo; J P Foreyt; C H Halsted; D Heber; D C Heimburger; C P Lucas; D C Robbins; J Chung; S B Heymsfield
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.